Levolin Inhaler
Indicated to address acute bronchoconstriction to relieve wheezing spasms and support easy respiration.
- Category
- Respiratory Health
- Active ingredient
- Levosalbutamol
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 50mcg
Prescription and consultation requirements for Levolin Inhaler vary by destination and are determined by the fulfilment partner.
Levolin Inhaler details
- Conditions
- Bronchospasm · Asthma
- Alternative names
- levosalbutamol
- Therapeutic class
- Beta-2 Adrenergic Agonist
- Pharmacological class
- Bronchodilator
- Contraindications
- hypersensitivity to levosalbutamol
- Minor side effects
- tremor; headache; cough
- Moderate side effects
- tachycardia; throat irritation; nervousness
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 5–10 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Beta Blockers; Diuretics; Digoxin
- Age restrictions
- Approved for children over four years and adults.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; severe hypokalaemia, requires immediate medical attention
Patient summary
indicated to address acute bronchoconstriction to relieve wheezing spasms and support easy respiration.
Mechanism of action
Selectively stimulates beta-2 receptors in bronchial smooth muscles, inducing relaxation to open narrowed airways rapidly.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits justify risks. Breastfeeding: Consult a clinician.